- Between laughs and 'disaster', Trump divides Davos
- Hundreds of people protest ahead of Swiss Davos meeting
- US falling behind on wind power, think tank warns
- US news giant CNN eyes 200 job cuts, streaming overhaul
- Rubio chooses Central America for first trip amid Panama Canal pressure
- Wall Street's AI-fuelled rally falters, oil slumps
- Trump tells Davos elites: produce in US or pay tariffs
- Progressive politics and nepo 'babies': five Oscar takeaways
- American Airlines shares fall on lackluster 2025 profit outlook
- France to introduce new sex education guidelines in schools
- Wall Street's AI-fuelled rally falters
- Drinking water in many French cities contaminated: study
- After Musk gesture, activists project 'Heil' on Tesla plant
- ICC prosecutor seeks arrest of Taliban leaders over persecution of women
- Syria's economy reborn after being freed from Assad
- Shoppers unaware as Roman tower lurks under French supermarket
- Stocks mainly rise after Wall Street's AI-fuelled rally
- Singer Chris Brown sues Warner Bros for $500 mn over documentary
- J-pop star Nakai to retire after sexual misconduct allegations
- Leaky, crowded and hot: Louvre boss slams her own museum
- WWF blasts Sweden, Finland over logging practices
- How things stand in China-US trade tensions with Trump 2.0
- Most Asian markets rise after Wall Street's AI-fuelled rally
- Fire-hit Hollywood awaits Oscar nominees, with 'Emilia Perez' in front
- New rider in town: Somalia's first woman equestrian turns heads
- Most Asian markets extend AI-fuelled rally
- Bangladesh student revolutionaries' dreams dented by joblessness
- Larry Ellison, tech's original maverick, makes Trump era return
- Political crisis hits South Korea growth: central bank
- Photonis Launches Two Market-Leading Solutions to Advance Single Photon Detection and Imaging Applications
- Les Paul owned by guitar god Jeff Beck auctioned for over £1 mn
- Musk bashes Trump-backed AI mega project
- Does China control the Panama Canal, as Trump claims?
- Yemen's Huthis say freed detained ship's crew after Gaza truce
- Mel B, Trump and Milei: What happened at Davos Wednesday
- Argentina's Milei says would leave Mercosur for US trade deal
- Fashion world 'afraid' of Trump, says Van Beirendonck
- P&G sees China improvement but consumers 'still struggling'
- Stock markets mostly higher as they track Trump plans, earnings
- Anti-Semitic acts at 'historic' highs in France despite 2024 fall: council
- Trump's meme coin venture sparks backlash
- Global green energy push likely to continue despite Trump climate retreat: UN
- Prince Harry settles lawsuit against Murdoch's UK tabloids
- Stock markets diverge tracking Trump plans
- Sudan 'political' banknote switch causes cash crunch
- Masa Son, Trump's Japanese buddy with the Midas Touch
- Borussia Dortmund sack coach Nuri Sahin after Champions League setback
- 'Love for humanity': Low-crime Japan's unpaid parole officers
- Brazil saw 79% jump in area burned by fires in 2024: monitor
- No home, no insurance: The double hit from Los Angeles fires
California start-up sends tiny robots on voyage into brains
Sending miniature robots deep inside the human skull to treat brain disorders has long been the stuff of science fiction -- but it could soon become reality, according to a California start-up.
Bionaut Labs plans its first clinical trials on humans in just two years for its tiny injectable robots, which can be carefully guided through the brain using magnets.
"The idea of the micro robot came about way before I was born," said co-founder and CEO Michael Shpigelmacher.
"One of the most famous examples is a book by Isaac Asimov and a film called 'Fantastic Voyage,' where a crew of scientists goes inside a miniaturized spaceship into the brain, to treat a blood clot."
Just as cellphones now contain extremely powerful components that are smaller than a grain of rice, the tech behind micro-robots "that used to be science fiction in the 1950s and 60s" is now "science fact," said Shpigelmacher.
"We want to take that old idea and turn it into reality," the 53-year-old scientist told AFP during a tour of his company's Los Angeles research and development center.
Working with Germany's prestigious Max Planck research institutes, Bionaut Labs settled on using magnetic energy to propel the robots -- rather than optical or ultrasonic techniques -- because it does not harm the human body.
Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately maneuver the micro-robot into the affected part of the brain, before removing it via the same route.
The entire apparatus is easily transportable, unlike an MRI, and uses 10 to 100 times less electricity.
- 'You're stuck' -
In a simulation watched by AFP, the robot -- a metal cylinder just a few millimeters long, in the shape of a tiny bullet -- slowly follows a pre-programed trajectory through a gel-filled container, which emulates the density of the human brain.
Once it nears a pouch filled with blue liquid, the robot is swiftly propelled like a rocket and pierces the sack with its pointed end, allowing liquid to flow out.
Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years.
If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children.
Sufferers of the congenital ailment can experience cysts the size of a golf ball, which swell and increase pressure on the brain, triggering a host of dangerous neurological conditions.
Bionaut Labs has already tested its robots on large animals such as sheep and pigs, and "the data shows that the technology is safe for us" human beings, said Shpigelmacher.
If approved, the robots could offer key advantages over existing treatments for brain disorders.
"Today, most brain surgery and brain intervention is limited to straight lines -- if you don't have a straight line to the target, you're stuck, you're not going to get there," said Shpigelmacher.
Micro-robotic tech "allows you to reach targets you were not able to reach, and reaching them repeatedly in the safest trajectory possible," he added.
- 'Heating up' -
The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas -- cancerous brain tumors often considered to be inoperable.
In the latter case, the micro-robots will be used to inject anti-cancer drugs directly into brain tumors in a "surgical strike."
Existing treatment methods involve bombarding the whole body with drugs, leading to potential severe side effects and loss of effectiveness, said Shpigelmacher.
The micro-robots can also take measurements and collect tissue samples while inside the brain.
Bionaut Labs -- which has around 30 employees -- has held discussions with partners for the use of its tech to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes.
"To the best of my knowledge, we are the first commercial effort" to design a product of this type with "a clear path to the clinic trials," said Shpigelmacher.
"But I don't think that we will be the only one... This area is heating up."
A.Samuel--CPN